Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially ...

The reliance of the pharmaceutical industry on data is fairly high for planning clinical trials, managing resources, and bringing new drugs to market. Yet one of its biggest challenges remains the ...

ProofPilot, the leading end-to-end clinical experience platform, today announced the acquisition of Lokavant, the ...

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in ...

SAN DIEGO, CA / ACCESS Newswire / September 11, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...

Risks for developing Alzheimer’s disease can increase or decrease depending on when women begin hormone replacement therapy, ...

As value-based care (VBC) continues to redefine reimbursement models and quality standards in skilled nursing facilities (SNFs), the Director of Nursing ...

A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs ...

From triage algorithms to digital twins, artificial intelligence is reshaping emergency care, delivering faster decisions, ...

A study published in JAMA Internal Medicine in 2023 concluded most common cancer screening tests do not “save lives by extending lifetime.”A new evaluation of the data used in that meta-analysis found ...